Skip to content
Alpha Poker Station

The Zimbabwean Government Declines ‘One-Sided’ American Healthcare Assistance Package Over Data Fears

Health funding image
The offered American financial assistance was aimed at programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has turned down a significant US health deal valued at 367 million US dollars (£272m) over five years because of the United States' demand for sensitive biological samples.

This move was revealed after a government memo from December was disclosed, which showed President Emmerson Mnangagwa deemed the deal was "skewed".

An official spokesman has since clarified that the United States was requesting health data for research and commercial gain while was unwilling to share the resulting advantages from any future vaccines.

"We will now turn to the difficult and regrettable task of winding down our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the US had furnished more than $1.9bn for health programmes to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has urged more dialogue to reach a agreement suitable to both sides so the nation's vital HIV programme can continue.

Wider Context

This rejection follows a similar case in neighbouring Kenya, where a court suspended a similar deal with the US after concerns were filed about the security of citizens' medical information.

Since returning to office last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).

USAID had administered aid for the American government, but Trump stated its spending was "inefficient" and his government was pursuing government-to-government agreements to boost openness and responsibility.

Based on statements, 16 nations in Africa have so far signed similar agreements, constituting over $18.3bn in committed funds.

Specifics of the Rejected Deal

The funds for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We believe this cooperation would have delivered significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy via US-supported initiatives," the Ambassador commented.

However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".

"Our nation was requested to provide its genetic material and health information over an extended period, with no corresponding promise of access to any medical innovations – like new medicines or tests – that could be developed from that provided information," Mangwana explained.

"Put simply, our nation would provide the basic resources for medical research with no certainty that the end products would be accessible to our people if a future pandemic arise."

Sovereignty and Global Health

Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were upending frameworks previously established via the international organization.

The spokesperson cited its Pandemic Benefit-Sharing framework created to deal with future global health emergencies.

"This system is designed to guarantee that when a country provides its data, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the resources to develop them."

These objections regarding the US deal "should not be misconstrued as opposition to America," he added.

"We encourage continued discussions with our American counterparts on how future co-operation could be designed in a way that respects the sovereignty and interests of each country."

Medical Community Response

A leading public health body stated it recognised the official position, but recommended that negotiations should continue since much of the nation's Aids initiatives were funded by international support.

"Where technical issues arise, such as those relating to data governance or implementation frameworks, these can often be addressed via detailed discussion and negotiated safeguards," the group added.

This impasse underscores the ongoing challenges between accepting vital international aid and safeguarding local interests in an ever more interconnected world.

The writer

Karen Parsons

Maya Chen is a professional poker player and strategist with over a decade of experience in high-stakes tournaments and cash games.

Alpha Poker Station

Type to search articles.